Trial NCT00766142

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000599511
Secondary IDs: EUDRACT-2006-003900 IB-2007-20 IB-COCHISE-I MERCK-IB-COCHISE-I

Last trial update was posted on 2021-01-26

MeSH Interventions

Calcium Cetuximab Fluorouracil Leucovorin Levoleucovorin Oxaliplatin

MeSH Conditions

Carcinoma Colorectal Neoplasms Peritoneal Neoplasms

Other Conditions

Colorectal Cancer Primary Peritoneal Cavity Cancer

Stopping Reasons

In 2008, new data highlighted that Cetuximab had no efficacy in case of KRAS mutation. As such, eligibility criteria were revised and limited to KRAS wild-type. Inclusions were thus slown down considerably, and the trial was stopped.

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID